Common emergencies in cancer medicine: infectious and treatment-related syndromes, Part II.

C. R. Thomas, K. J. Stelzer, J. G. Douglas, W. J. Koh, L. V. Wood, R. Panicker

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


This article completes a summary of the common medical emergencies that can occur as a result of infectious processes (Part I) and antitumor treatment secondary to chemotherapy, biological response modifiers, or radiotherapy (Part II). The use of high-dose cytotoxic agents, coupled with the common instillation of indwelling central venous access devices, have altered the spectrum of infectious etiologies that are appreciated in clinical practice. In addition, a myriad of cytotoxic agents and radiotherapeutic treatment schemes are used widely in clinical oncologic practice. While most of their related side effects are not considered life-threatening emergencies, they can be fatal if not recognized early and treated promptly. Moreover, some of these infectious and treatment-related sequelae can be prevented. This article highlights some of these clinical observations.

Original languageEnglish (US)
Pages (from-to)839-852
Number of pages14
JournalJournal of the National Medical Association
Issue number11
StatePublished - Nov 1994
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Common emergencies in cancer medicine: infectious and treatment-related syndromes, Part II.'. Together they form a unique fingerprint.

Cite this